ALHI

MRFF grant recipient, currently developing the world’s first zero-dose lung scanner. It is a new frontier in lung health for children!

[ALHI @_ALHI_]

Breathing hope into the lives of people affected by lung disease. https://t.co/sL6LYArDmA @UoA_Innovation @4DMedicalXV #COPD #MedEd #pulmonary

[ALHI @_ALHI_]

Developing world’s first dedicated lung function scanners, with a vision towards zero dose imaging. #pulmonary #MedEd #MedTech #MedTwitter @4DMedicalXV #COPD #COVIDー19

[ALHI @_ALHI_]

https://t.co/Uo95FtTExJ #mrff #4Dlungs #pulmonary @healthgovau @UniofAdelaide @sahmriAU @MonashUni

[ALHI @_ALHI_]

"$100 Million for Major Advances in Medical Research Technology"
https://t.co/Uo95FtTExJ

[ALHI @_ALHI_]

We did it!!! Frontiers submission is in. Thanks to all of the ALHI partners, teams of people and admin support staff that made the last 12 months possible. We could not have done it without you. #MRFF https://t.co/GKfIkzJKQR

[larisachisholm @larisachisholm]

Delighted to receive an "FDA Cleared" T-shirt in the mail from @_ALHI_ industry partner @4DMedicalXV. Nice fit. Congratulations to the team on a great milestone delivered.

[ALHI @_ALHI_]

COVID-19 has impacted the conduct of lung function testing globally, with a return to spirometry creating challenges such as use of PPE. Our XVD imaging together with @4DMedicalXV algorithm represents a safe alternative to PFT's https://t.co/eIyaIBekPZ #lungfunction #lungimaging

[ALHI @_ALHI_]

The XVD technology we are developing will provide sensitive safe imaging & together with @4DMedicalXV algorithm provides an evidence based tool that clinically evaluates patient responses quantitatively, as opposed to patient surveys currently in use.

[ALHI @_ALHI_]

It's time to raise respiratory awareness! While a major cause of disease burden, there is little spent on developing new respiratory drugs, no tools for quantitating lung function and few options for testing young children or cognitively impaired. https://t.co/TOcOkdFPvW

[ALHI @_ALHI_]

Some patients discharged after COVID-19 infection show signs of restricted lung function. Ongoing monitoring of these patients will hopefully help with understanding pathophysiology of this disease. https://t.co/4UWAJ6Kvev

[ALHI @_ALHI_]

The metrics of respiratory disease in Australia: while not the highest cause of mortality, COPD (#3) and Asthma (#10) collectively have a higher overall burden (DALY) on our health system than our #1 killer - heart disease! https://t.co/VnpeJHfJfl

[ALHI @_ALHI_]

@_ALHI_ 's imaging hardware and @4DMedicalXV software will revolutionise lung function testing for patients, allowing them to be upright, breath normally and offers low radiation dose. For the first time, very young children will be able to have lung function testing performed.

[ALHI @_ALHI_]

The imaging hardware being developed by ALHI partners together with FDA approved XV technology from @4DMedicalXV Medical will for the first time provide a way to accurately quantitate and localise the extent of lung disease. Rapid, affordable and safe imaging for all patients!

[4DMedical @4DMedicalXV]

We're now FDA approved! https://t.co/GMc4y1mQEp

[ALHI @_ALHI_]

Congrats to our industry partner @4DMedicalXV on your FDA approval for your lung ventilation technology! We are so proud to be developing the hardware that complements this amazing tech which will benefit all patients with lung disease, especially kids. https://t.co/3qtMjYbNfQ

[ALHI @_ALHI_]

May is Lung Health awareness month. Some of ALHI's partners are working to develop life changing technologies for our most vulnerable communities. Read about their field ventilator collaboration here https://t.co/kvK4zrW9NN
#lunghealth #COVID19

[TSANZ @tsanz_thoracic]

Now more than ever it’s important to know the symptoms of pneumonia: https://t.co/N62t2WwEte #pneumoniaawarenessweek

[ALHI @_ALHI_]

Scientists and engineers from several ALHI partners have collaborated to develop an affordable field ventilator for use in remote and regional hospitals. Hear Assoc Prof David Parsons being interviewed about this ventilator project. #lunghealth https://t.co/16IKDRRorS

[ALHI @_ALHI_]

Today, May 5, is World Asthma Day. Did you know that asthma is the most prevalent chronic respiratory condition worldwide, affecting some 358 million people in 2015? #lunghealth #asthma

[ALHI @_ALHI_]

The hidden cost of asthma. In 2015 Deloitte reported total costs from 1990-2015 were almost $35Bn. Cost was $11,470pp. Highest costs were attributable to 0-4 age bracket. We need improved tools for early diagnosis, treatment and monitoring in children. https://t.co/lQfUedgCxi

[ALHI @_ALHI_]

May 5 is World Asthma Day. In Australia 11.2% or 2.7 million people suffer from asthma. Prevalence is even higher among kids at 17% of 0-14 yo and 18% among our indigenous populations. Its important to monitor asthma as a disease, don't just treat the symptoms when you have them.